RAT SNCA, ALPHA-SYNUCLEIN, 100PG/ML-40NG/ML ASSAY RANGE, ELISA KIT (Part SNCa-Biotin) kw: alpha synuclein,

RAT SNCA, ALPHA-SYNUCLEIN, 100PG/ML-40NG/ML ASSAY RANGE, ELISA KIT (Part SNCa-Biotin) kw:  alpha synuclein,
Click to enlarge
Price: $635.00
Availability: In Stock
Model: rSNCa-Biotin

Available Options:
Rat Alpha-Synuclein (SNCa) ELISA Kit
 
Dynamic Assay Range: 100pg/ml - 40ng/ml.  Sensitivity: 0.08ng/ml.
Lead Time:  Approximately 1.5 week

Specifications
  • Fully pre-configured ELISA kit in sandwich assay format.
  • Standard peptide concentration:  32ng/ml
  • Dynamic Assay Range: 100pg/ml - 30ng/ml.  Sensitivity: 0.08ng/ml.
  • Rapid ELISA Protocol:  Requires one 60 min incubation period at 37oC.
  • Samples are mixed with the provided biotinylated detection antibody and provided streptavidin-HRP prior to addition to plate.
  • Available in 48T and 96T formats.
  • 48T Kit Cost:  $335.  96T Kit Cost:  $635. 2 x 96T Cost:  $1150


Number of Assays
Cost
48T
$355
96T
$635
2 x 96T
$1150

  Protocol

Methods Overview:

The included ELISA micro-strip plate is provided pre-coated with an a monoclonal capture antibody selective to the antigen.  Samples are pre-mixed with a biotin-linked detection antibody and streptavidin-HRP, which are then added to the plate.  The plate is washed after a 60 min incubation period.  Color reagents are added, resulting in a reaction with HRP that yields a blue colored solution.  A stop solution is applied to terminate the reaction, and the solution is measured at 450nm.  


   Sandwich ELISA Methods to Alpha Synuclein (SNCa)                                                       

ELISA Assay Steps
  1. Mix sample, provided biotinylated-detection antibody and provided streptavidin-HRP.
  2. Apply sample and antibody-HRP complex to ELISA plate for 60min at 37oC.  Wash 5 times.
  3. Apply chromogens, incubate, then stop reaction.



Introduction to Alpha Synuclein:   
Alpha-synuclein is a 140 amino acid protein expressed in brain that is associated with fibrillar structures in Lewy Bodies. Alpha-synuclein binds to phospholipid and may assemble into pore-like structures in cellular membranes, but it is primarily located in the cytosol.  Generation of aggregates in Lewy Bodies and/or association of mutant or wild-type alpha-synuclein with membraneous structures have been linked to both early-onset congenital and age-related Parkinson’s Disease. Parkinson's disease is a neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability.  Additional features of the disease include postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies in brain and spinal cord.   

Gerneral References on Alpha Synuclein
  1. Adamczyk, A. et al. (2007) Alpha-synuclein decreases arachidonic acid incorporation into rat striatal synaptoneurosomes. Folia Neuropathol45 (4), 230-235
  2. Kim, H.J. et al. (2007) Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment. J Microbiol Biotechnol 17 (12), 2027-2032
  3. Wakabayashi, K. et al. (2007) The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27 (5), 494-506
  4. Yoshida, M. (2007) Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 27 (5), 484-493
  5. Kloepper, K.D. et al. (2007) Solid-state NMR spectroscopy reveals that water is nonessential to the core structure of alpha-synuclein fibrils. J Phys Chem B 111 (47), 13353-13356
  6. Buchman, V.L. and Ninkina, N. (2008) Modulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies--is the juice worth the squeeze? Neurotox Res 14 (4), 329-341
  7. Fuchs, J. et al. (2008) Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. Faseb J 22 (5), 1327-1334
  8. Parihar, M.S. et al. (2009) Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int J Biochem Cell Biol 41 (10), 2015-2024
  9. Gibrat, C. et al. (2009) Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J Neurochem 109 (5), 1469-1482
  10. Kim, S. et al. (2009) Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP. J Neurochem 109 (5), 1483-1496
  11. Leong, S.L. et al. (2009) Modulation of alpha-synuclein aggregation by dopamine: a review. Neurochem Res 34 (10), 1838-1846
  12. Xilouri, M. et al. (2009) Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.PLoS One 4 (5), e5515
  13. Noguchi-Shinohara, M. et al. (2009) CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease. Brain Res 1251, 1-6

For research only.  Not for diagnostics.
Safety:  Stop solution contains acid.   Avoid ingestion, skin and eye contact.
Storage:  4°C. 6 months.
Shipping.  Overnight domestic delivery recommended with ice pack (cost: $42 for 1-2 kits).  Also avaialble for international delivery; please inquire for shipping cost. 


 

Category Download Link
Protocol Manual click here
MSDS click here